| 06/01/2001 | IOC Issues New List of Prohibited Substances and MethodsThe World Anti-Doping Agency (WADA), in collaboration with the International Olympic Committee (IOC), today in Lausanne released the new list of prohibitedsubstances and methods that will help guide doping control within the Olympic Movement from 1 September 2001 until at least 31 December 2002. By distributing the list yesterday, WADA and the IOC have provided the International Sports Federations (IFs), the National Olympic Committees (NOCs), and other Olympic partners with the required three-month notice period before the new list goes into effect. The current list, published in 2000, will remain effective until 31 August 2001.
"WADA welcomes the changes adopted in this list, especially the new definition of blood doping and the tougher requirement for asthma medications. We will, however, continue to look for ways to improve it," said WADA Chairman Richard W. Pound. "We already have a process underway that is studying how to further refine the list for 2003."
The new list, which contains generic categories of prohibited substances and methods, as well as specific examples of them, includes four significant changes to the list in force today. One, the definition of blood doping, as stated in the Olympic Movement Anti-Doping Code, has been added as a prohibited method. Two, an additional requirement has been added for athletes who seek authorization to use asthma medications containing beta 2 agonists during the Olympic Games. These athletes will now have to submit clinical proof to a medical review panel and may be subject to on-the-spot tests to substantiate their ailment and need for beta 2 agonists. In a related matter, the use of inhaled formoterol and salmeterol, which contain beta 2 agonists, will be permitted only as long as the pre-competition notification requirements are fulfilled. Three, IFs may now require notification before permitting the use of glucocorticosteroids, which are allowed if administered by local or intra-articular injection. Four, the list's set of examples has been expanded to include bupropion, a stimulant, and aromatase inhibitors, hormonal agents that inhibit the production of aromatase, an enzyme the body uses to convert endocrine substances, such as androgen, into estrogen.
The new list was approved by the IOC Executive Board during its meeting on 17 May 2001, upon the recommendation of WADA and in agreement with the IOC Medical Commission as stipulated by Chapter VII, Article 2, of the Olympic Movement Anti-Doping Code. The new list will replace the current one as Appendix A of that Code. The new list can be found on WADA's web site: www.wada-ama.org.www.wada-ama.org
|
|
|
